Pfizer released a report Tuesday with first-quarter results that beat analysts. The earnings figure exceeded estimates.

The company reported earnings per share of $1.62, with revenues totaling $25.66B. Analysts surveyed by Investing.com had anticipated in forecasts that EPS would be $1.52 and total revenue would be $24.1B $

Pfizer’s stock price, down 5% this year, has performed better than the overall S&P 500 index, down 12% YTD.

PFIZER FOLLOWS THE GENERAL TREND OF HEALTH CARE COMPANIES THIS MONTH

On April 14, UnitedHealth reported first quarterly earnings of $5.49, with earnings of $80.15B, compared to EPS estimates of $5.36 for total revenues of $78.73B

J&J’s earnings beat analysts’ expectations in the April 19 first quarter, with quarterly EPS of $2.67 on total revenue of $23.43B $ Analysts at Investing.com had previously predicted EPS of $2.59 on total revenue of $23.62B $